Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Holders of 5% or more of LABP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Landos Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Landos Biopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Landos Biopharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 6, 2021 | Perceptive Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 18, 2021 | Perceptive Advisors LLC | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | RTW Investments, LP | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Landos Biopharma, Inc. shares.
No Form 144 notices for Landos Biopharma, Inc. are on file.